Register Login

FIBROBIOLOGICS, INC. (FBLG)

SymbolFBLG
NameFIBROBIOLOGICS, INC.
SectorHEALTH CARE
RegionNorth America
IndustryBiotechnology: Pharmaceutical Preparations
Address455 EAST MEDICAL CENTER BOULEVARD,SUITE 300,HOUSTON, TEXAS, Texas, 77598, United States
Telephone281 671 5150
Fax—
Email—
Websitehttps://www.fibrobiologics.com
IncorporationUNDEFINED
Incorporated On—
Employees—
Fiscal Year—
Public Since—
ExchangesNASDAQ
Auditor—
Audit StatusNOT PROVIDED
Reporting Status—
CIK0001958777
Description

FibroBiologics, Inc. operates as a clinical-stage cell therapy company that focuses on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs. The company develops CybroCell for degenerative disc disease; CYMS101 to treat multiple sclerosis; and CYWC628 for treating wound healing. Its early-stage research programs include CYTER915 which is designed to regenerate or reinvigorate production of the thymus and/or spleen; and TCB190 for the treatment of cancers. The company was incorporated in 2021 and is based in Houston, Texas. FibroBiologics, Inc. operates as a subsidiary of Spinalcyte Llc.

Additional info from NASDAQ:
FibroBiologics, Inc. operates as a clinical-stage cell therapy company that focuses on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs. The company develops CybroCell for degenerative disc disease; CYMS101 to treat multiple sclerosis; and CYWC628 for treating wound healing. Its early-stage research programs include CYTER915 which is designed to regenerate or reinvigorate production of the thymus and/or spleen; and TCB190 for the treatment of cancers. The company was incorporated in 2021 and is based in Houston, Texas. FibroBiologics, Inc. operates as a subsidiary of Spinalcyte Llc.

2026-05-06 11:02

(99% Neutral) FIBROBIOLOGICS, INC. (FBLG) Announces Business Combination

Read more
2026-05-05 11:21

(99% Neutral) FIBROBIOLOGICS, INC. (FBLG) Announces Executive Changes

Read more
2026-05-05 08:19

New Form ARS - FibroBiologics, Inc. <b>Filed:</b> 2026-05-05 <b>AccNo:</b> 0001193125-26-205037 <b>Size:</b> 4 MB

Read more
2026-05-05 08:19

New Form DEFA14A - FibroBiologics, Inc. <b>Filed:</b> 2026-05-05 <b>AccNo:</b> 0001193125-26-205035 <b>Size:</b> 2 MB

Read more
2026-05-05 08:18

New Form DEF 14A - FibroBiologics, Inc. <b>Filed:</b> 2026-05-05 <b>AccNo:</b> 0001193125-26-205032 <b>Size:</b> 4 MB

Read more
2026-05-04 23:01

Director O'HEERON PETE 🟢 acquired 92.4K shares (1 derivative) of FibroBiologics, Inc. (FBLG) at $1.38 Transaction Date: May 04, 2026 | Filing ID: 021175

Read more
2026-05-04 23:00

Khoja Hamid 🟢 acquired 61.6K shares (1 derivative) of FibroBiologics, Inc. (FBLG) at $1.38 Transaction Date: May 04, 2026 | Filing ID: 021174

Read more
2026-05-04 23:00

Davis Jason 🟢 acquired 61.6K shares (1 derivative) of FibroBiologics, Inc. (FBLG) at $1.38 Transaction Date: May 04, 2026 | Filing ID: 021173

Read more
2026-05-04 23:00

GARCIA RUBEN A 🟢 acquired 61.6K shares (1 derivative) of FibroBiologics, Inc. (FBLG) at $1.38 Transaction Date: May 04, 2026 | Filing ID: 021172

Read more
2026-05-04 20:01

FibroBiologics Reports Preclinical Data Showing Fibroblast Spheroids May Actively Reprogram the Burn Wound Environment to Drive Healing and Reduce Scarring

Read more